Ativismo, políticas públicas e acesso a medicamentos: o uso de oposições a pedidos de patentes por organizações da sociedade civil / Activism, public policies and access to medicines: the use of patent oppositions by civil society organizations
Physis (Rio J.)
; 28(1): e280107, 2018.
Article
in Portuguese
| LILACS
| ID: biblio-895650
Responsible library:
BR433.1
RESUMO
Resumo O artigo aborda o problema do acesso aos medicamentos ARVs e a construção da agenda de lutas do movimento social da AIDS, especificamente o caso do tenofovir, suas pró-drogas e a combinação com a emtricitabina. Discute de que estratégias o movimento AIDS lançou mão para evitar que tais medicamentos fossem patenteados, utilizando o método monográfico e a posição de insider do autor para fazer a análise.
ABSTRACT
Abstract This article brings the issue of access to ARV drugs and the construction of the struggles agenda of the Aids social movement regarding the tenofovir case as well as its prodrugs and the combination with emtricitabine. The article discusses which strategies the HIV movement used to avoid the patenting of such drugs, using the monographic method and the author's inside position to conduct this analysis.
Full text:
Available
Collection:
International databases
Health context:
Sustainable Health Agenda for the Americas
/
SDG3 - Health and Well-Being
Health problem:
Goal 5: Medicines, vaccines and health technologies
/
Target 3.8 Achieve universal access to health
/
Target 3.3: End transmission of communicable diseases
Database:
LILACS
Main subject:
Brazil
/
Acquired Immunodeficiency Syndrome
/
HIV
/
Intellectual Property of Pharmaceutic Products and Process
/
Tenofovir
/
Political Activism
/
Access to Essential Medicines and Health Technologies
Country/Region as subject:
South America
/
Brazil
Language:
Portuguese
Journal:
Physis (Rio J.)
Journal subject:
Public Health
Year:
2018
Document type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
Universidade do Estado do Rio de Janeiro/BR